Equity Analysis

Quarterly Results

    Dr Reddys Laboratories Ltd
    Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
    BSE Code
    ISIN Demat
    Book Value()
    500124
    INE089A01031
    322.4732712
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    DRREDDY
    18.75
    97185.36
    EPS(TTM)
    Face Value()
    Div & Yield %:
    62.12
    1
    0.69
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2024Sep 2024Jun 2024
Gross Sales4997.806678.805823.90
Other Operating Income17.2017.5017.30
Other Income 235.40207.60217.80
Total Income5250.406903.906059.00
Total Expenditure 3822.603974.703888.20
PBIDT1427.802929.202170.80
Interest 43.3028.407.10
PBDT1384.502900.802163.70
Depreciation265.10260.00249.80
Tax256.30703.30466.60
Fringe Benefit Tax0.000.000.00
Deferred Tax13.7055.4030.10
Reported Profit After Tax849.401882.101417.20
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item849.401882.101417.20
EPS (Unit Curr.)10.20113.0085.10
EPS (Adj) (Unit Curr.)10.2022.6017.02
Calculated EPS (Unit Curr.)10.18112.8484.96
Calculated EPS (Adj) (Unit Curr.)10.1822.5716.99
Calculated EPS (Ann.) (Unit Curr.)40.74451.34339.86
Calculated EPS (Adj) (Ann.) (Unit Curr.)40.7490.2767.97
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity83.4083.4083.40
Reserve & Surplus0.000.000.00
Face Value1.005.005.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)28.5743.8637.27
PBDTM(%)27.7043.4337.15
PATM(%)17.0028.1824.33
Dividend Per Share(Rs)0.000.000.00
Diluted EPS10.18112.8084.97